SPC
XERS icon

Sigma Planning Corp’s Xeris Biopharma Holdings XERS Stock Holding History

Sigma Planning Corp’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,050
Closed -$46.9K – 1385
2025
Q2 		$46.9K Sell
10,050
-63,900
-86% -$293K ﹤0.01% 1230
2025
Q1 		$406K Sell
73,950
-3,000
-4% -$12.1K 0.01% 813
2024
Q4 		$261K Sell
76,950
-1,500
-2% -$4.83K 0.01% 984
2024
Q3 		$224K Hold
78,450
– – 0.01% 1090
2024
Q2 		$177K Buy
78,450
+1,900
+2% +$3.83K 0.01% 1106
2024
Q1 		$169K Buy
+76,550
New +$198K 0.01% 1150

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Sigma Planning Corp's XERS Position: Q3 2025 in Review

Sigma Planning Corp sold out of Xeris Biopharma Holdings (XERS) in Q3 2025, closing a stake of 10,050 shares — an estimated $46.9K sold.

Sigma Planning Corp first reported a position in XERS in Q1 2024 and held it in 6 quarters. The position peaked at $406K in Q1 2025. 230 funds tracked by Wall St. Rank hold XERS as of Q3 2025.

  • Sigma Planning Corp reported no remaining Xeris Biopharma Holdings position as of Q3 2025 after selling out during the quarter.
  • Sigma Planning Corp sold 10,050 Xeris Biopharma Holdings shares in Q3 2025, an estimated $46.9K.
  • Sigma Planning Corp first reported a position in Xeris Biopharma Holdings in Q1 2024 and held it in 6 quarters.
  • Sigma Planning Corp's Xeris Biopharma Holdings position peaked at $406K in Q1 2025.
  • 230 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2025.

Based on Sigma Planning Corp's 13F filing for Q3 2025, filed 10 Nov 2025.